Svein holds a Master of Science degree in Business from the Norwegian School of Management, BI, and has wide commercial experience. From 1990 to 1993, he was a Director of Teknoinvest, a Norwegian venture company. From 1993 he was appointed President of Axis Biochemicals ASA. Svein later became Joint Managing Director of Axis-Shield plc when Axis Biochemicals ASA merged with Shield Diagnostics Group plc in May 1999 and was later appointed Chief Executive Officer for the Group. He stepped down from this role at year end 2007 and became Partner in Cubera Private Equity from spring 2008 until autumn 2009. He then spent time building up his own consultancy and advisory business before taking over as CEO of Biotec Pharmacon from mid March 2010. Beside these full time positions, Svein has also been involved in a number of high tech companies mostly in life science and still holds a few Board positions. Number of shares held by Svein and close associates: 298,121. Number of options in Biotec Pharmacon held by Svein: 200,000.